Agree. Admedus terminated the agreement because they couldn't get a more competitive price from their manufacturer/supplier. They will look for a new one and carry on. If they didn't they would lose customers. Its unreasonable to think they can't find a better supplier, there are newer and more sophisticated products all the time from other manufacturers.
All the speculation about losing customer contracts was just nonsense.
As I recall they forecast was to break even in the last quarter of 2018 and be profitable for 2019. I don't see the statement being that much different...
Back to more important things.
Ann: Conclusion of relationship with Go Medical Industries, page-37
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M | |||
| Open | High | Low | Value | Volume |
| $16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $15.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 700 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |